When Revlon Inc. announced that it would miss its revenue growth forecasts for the year, stockholders saw shares of the company plunge nearly 40%, and analysts spared no ink cautioning potential investors…
Revlon’s new Vital Radiance brand and repositioning of Almay—which together cost the company $62 million in 2005—appeared on track to meet sales expectations when first-quarter results were announced, but subsequent data showed that sales for the brands are less than expected. The efforts were Revlon’s “first real growth initiatives in years, but they also seemed to us to be last-ditch efforts,” according to Morningstar analysts, reflecting fundamental problems at Revlon and its ability to successfully execute on the shelves. Further, analysts believes the company has been caught off guard by the aggressiveness of competitors and the shortened timeline retailers allow for new brands to prove themselves…
As Morningstar notes, and a lesson to the industry as a whole, the decline of Revlon demonstrates that a strong brand does not necessarily equate to a strong company.
For the full Stock Watch on Revlon, see the August issue of GCI.
Stock Watch: Revlon
July 14, 2006
Most Popular in Financials
- 315What's Driving L'Oreal's Growth?
- 165Coty to Boost Investment in Power Brands and Reorganization
- 138Avon Decline Led by Divestments, Latin American Challenges
- 131Sally Beauty Holdings Reports Results
- 125L'Oréal Marks Growth in Key Areas
- 94Beiersdorf Releases 2015 Business Results
- 71Oriflame Reports Challenging Results, Growth in Key Markets
- 61Perfume Results Negatively Impact Art & Fragrance Results
- 54L'Oréal Sales €22.9 Billion for 2013, Up 5%
- 51Inter Parfums Provides 2016 Initial Guidance